AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3 | -100.0% | 300 | -69.4% | 0.00% | – |
Q3 2022 | $10,000 | -16.7% | 980 | -13.0% | 0.00% | – |
Q2 2022 | $12,000 | -7.7% | 1,126 | -19.2% | 0.00% | – |
Q1 2022 | $13,000 | -45.8% | 1,394 | -35.1% | 0.00% | – |
Q4 2021 | $24,000 | +140.0% | 2,149 | +87.7% | 0.00% | – |
Q3 2021 | $10,000 | -9.1% | 1,145 | -5.7% | 0.00% | – |
Q2 2021 | $11,000 | +1000.0% | 1,214 | +635.8% | 0.00% | – |
Q1 2021 | $1,000 | -95.8% | 165 | -84.3% | 0.00% | – |
Q4 2020 | $24,000 | -83.2% | 1,048 | -89.8% | 0.00% | -100.0% |
Q3 2020 | $143,000 | +0.7% | 10,239 | +9.1% | 0.00% | 0.0% |
Q2 2020 | $142,000 | +63.2% | 9,381 | -0.4% | 0.00% | 0.0% |
Q1 2020 | $87,000 | -28.7% | 9,414 | -24.7% | 0.00% | -50.0% |
Q4 2019 | $122,000 | +4.3% | 12,500 | -14.1% | 0.00% | 0.0% |
Q3 2019 | $117,000 | -18.8% | 14,550 | +25.9% | 0.00% | 0.0% |
Q2 2019 | $144,000 | +14300.0% | 11,558 | +18246.0% | 0.00% | – |
Q1 2019 | $1,000 | -99.7% | 63 | -99.7% | 0.00% | -100.0% |
Q2 2018 | $299,000 | +3.8% | 19,169 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $288,000 | – | 19,169 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |